A combination device/drug product that delivers local hyperthermia concomitantly with intravesical mitomycin C for adjuvant therapy following transurethral resection of superficial transitional cell carcinoma of the bladder in patients at intermediate or high risk for tumor recurrence.

If you have a Hayes login, click here to view the full report on the Knowledge Center.